Esteva, Francisco J <br/><br/>
CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer.  [electronic resource] 

 -  Breast cancer research : BCR  2007 
 - R87 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1465-542X 
<br/><br/><label>Standard No.: </label>10.1186/bcr1836  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Biomarkers, Tumor--metabolism<br/>Biopsy, Fine-Needle<br/>Breast Neoplasms--drug therapy<br/>CD40 Antigens--metabolism<br/>Cyclophosphamide--administration & dosage<br/>Epirubicin--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Mastectomy--methods<br/>Mastectomy, Modified Radical<br/>Mastectomy, Segmental<br/>Middle Aged<br/>Neoadjuvant Therapy--methods<br/>Neoplasm Staging<br/>Neoplasm, Residual<br/>Paclitaxel--administration & dosage<br/>Predictive Value of Tests<br/>RNA, Messenger--metabolism<br/>Receptor, ErbB-2--genetics<br/>Signal Transduction<br/>Transcription, Genetic<br/>Trastuzumab<br/>Treatment Outcome<br/>Up-Regulation